{"text": "Patients who had both baseline and at least one post - baseline measurement were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .", "label": "", "metadata": {}, "score": "83.31572"}
{"text": "Patients who had both baseline and at least one post - baseline measurement were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .", "label": "", "metadata": {}, "score": "83.31572"}
{"text": "Patients who had both baseline and at least one post - baseline measurement were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .", "label": "", "metadata": {}, "score": "83.31572"}
{"text": "Time Frame .24 Week last patient last visit .Safety Issue .Yes .Population Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "85.77061"}
{"text": "Time Frame .24 Week last patient last visit .Safety Issue .Yes .Population Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "85.77061"}
{"text": "Number of Patients With Laboratory Adverse Experiences ( LAEs )Through 24 Weeks .Measure Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "86.534645"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Patients who had both baseline and at least one post - baseline measurement were included in the analysis .", "label": "", "metadata": {}, "score": "86.86743"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Patients who had both baseline and at least one post - baseline measurement were included in the analysis .", "label": "", "metadata": {}, "score": "86.86743"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Patients who had both baseline and at least one post - baseline measurement were included in the analysis .", "label": "", "metadata": {}, "score": "86.86743"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Patients who had both baseline and at least one post - baseline measurement were included in the analysis .", "label": "", "metadata": {}, "score": "86.86743"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Patients who had both baseline and at least one post - baseline measurement were included in the analysis .", "label": "", "metadata": {}, "score": "86.86743"}
{"text": "Of those , 79.9 percent ( 897 ) tested negative , 14.7 percent ( 167 ) were MSSA positive , and 6.5 percent ( 73 ) were MRSA positive .", "label": "", "metadata": {}, "score": "91.95091"}
{"text": "Number of Patients With Serious CAEs Through 24 Weeks [ units : Participants ] .No statistical analysis provided for Number of Patients With Serious CAEs Through 24 Weeks .", "label": "", "metadata": {}, "score": "92.696335"}
{"text": "Number of Participants Analyzed [ units : participants ] .Number of Patients That Discontinued Due to LAEs Through 24 Weeks [ units : Participants ] .", "label": "", "metadata": {}, "score": "95.01094"}
{"text": "The researchers examined data on all adult patients undergoing major GI surgery at their institution from December 2007 to August 2009 .All patients were tested with a nasal swab for MRSA colonization within 24 hours after admission .", "label": "", "metadata": {}, "score": "96.609344"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .All patients who took study medication were included in the analysis .Reporting Groups .", "label": "", "metadata": {}, "score": "97.137665"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .All patients who took study medication were included in the analysis .Reporting Groups .", "label": "", "metadata": {}, "score": "97.137665"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .All patients who took study medication were included in the analysis .Reporting Groups .", "label": "", "metadata": {}, "score": "97.137665"}
{"text": "Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "98.61194"}
{"text": "Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "98.61194"}
{"text": "Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "98.61194"}
{"text": "Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "98.61194"}
{"text": "Safety Issue .Yes .Population Description .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "102.42796"}
{"text": "Number of Patients With Serious LAEs Through 24 Weeks [ units : Participants ] .No statistical analysis provided for Number of Patients With Serious LAEs Through 24 Weeks .", "label": "", "metadata": {}, "score": "103.77405"}
{"text": "Number of Patients With Laboratory Adverse Experiences ( LAEs )Through 24 Weeks [ units : Participants ] .No statistical analysis provided for Number of Patients With Laboratory Adverse Experiences ( LAEs )", "label": "", "metadata": {}, "score": "106.003555"}
{"text": "\" A cost - benefit analysis needs to be done before we determine if this is something we need to universally do for GI surgeries ; I think that 's the next major starting point , \" he said in an interview with MedPage Today .", "label": "", "metadata": {}, "score": "108.57118"}
{"text": "Presence of a surgical site infection and positive MRSA nasal swab were both significantly associated with an increased length of patient stay , though positive result for MRSA in wound culture was not .", "label": "", "metadata": {}, "score": "108.64307"}
{"text": "The researchers suggested that using the nasal swabs to test for MRSA could help reduce the incidence of surgical site infection and length of stay in GI surgery patients .", "label": "", "metadata": {}, "score": "109.06328"}
{"text": "By 2009 , the researchers had graduated to using automated data mining systems that require far less user input , taking advantage of the enormous quantities of data that are being amassed by global companies .", "label": "", "metadata": {}, "score": "109.20209"}
{"text": "In Studies 1 and the mean bioavailability of parallel , double - blind , controlled clinical and furosemide oral solution is 64 % and 60 % , and dexamethasone was compared an intravenous injection of the drug .", "label": "", "metadata": {}, "score": "109.50583"}
{"text": "No statistical analysis provided for Number of Patients With Clinical Adverse Experiences ( CAEs )Through 24 Weeks .Mean Percent Change From Baseline in Fasting Serum Cholesterol at Week 12 .", "label": "", "metadata": {}, "score": "109.719536"}
{"text": "Drug - related are as assessed by an investigator who is a qualified physician , according to his / her best clinical judgement .Time Frame .", "label": "", "metadata": {}, "score": "110.7238"}
{"text": "the staff there was as bad as before to that observed when pressure to the point ( to a blood alcohol an increased risk of .", "label": "", "metadata": {}, "score": "111.39996"}
{"text": "Mean Percent Change From Baseline in Non - high - density Lipoprotein Cholesterol ( Non - HDL - C ) at Week 24 .Measure Description .", "label": "", "metadata": {}, "score": "112.21431"}
{"text": "Mean Percent Change From Baseline in Non - high - density Lipoprotein Cholesterol ( Non - HDL - C ) at Week 12 .Measure Description .", "label": "", "metadata": {}, "score": "112.70605"}
{"text": "More than one race .Unknown or Not Reported .Cluster of Differentiation 4 ( CD4 ) Cell Count [ units : cells / mm3 ] Mean ( Full Range ) .", "label": "", "metadata": {}, "score": "112.844086"}
{"text": "Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Number of Patients With Clinical Adverse Experiences ( CAEs )", "label": "", "metadata": {}, "score": "114.07978"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Number of Participants Analyzed [ units : participants ] .Number of Patients That Discontinued Due to CAEs Through 24 Weeks [ units : Participants ] .", "label": "", "metadata": {}, "score": "114.94527"}
{"text": "CAEs .Time Frame .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "115.60506"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Number of Participants Analyzed [ units : participants ] .Number of Patients With Clinical Adverse Experiences ( CAEs )", "label": "", "metadata": {}, "score": "115.73036"}
{"text": "There are typically 6 to 8 ends in a game lasting an 1.5 to 2 hours .The team with the most points wins the game .", "label": "", "metadata": {}, "score": "116.267914"}
{"text": "Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "116.3686"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Number of Participants Analyzed [ units : participants ] .Number of Patients With Drug - related CAEs Through 24 Weeks [ units : Participants ] .", "label": "", "metadata": {}, "score": "116.53772"}
{"text": "All patients who took study medication were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "116.853035"}
{"text": "All patients who took study medication were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "116.853035"}
{"text": "All patients who took study medication were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "116.853035"}
{"text": "All patients who took study medication were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "116.853035"}
{"text": "All patients who took study medication were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "116.853035"}
{"text": "All patients who took study medication were included in the analysis .Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "116.853035"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Number of Participants Analyzed [ units : participants ] .Number of Patients With Serious Drug - related CAEs Through 24 Weeks [ units : Participants ] .", "label": "", "metadata": {}, "score": "117.09519"}
{"text": "Time Frame .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "117.184906"}
{"text": "Time Frame .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "117.184906"}
{"text": "Mean Percent Change From Baseline in Fasting Serum High - density Lipoprotein Cholesterol ( HDL - C ) at Week 24 .Measure Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "117.1877"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Number of Participants Analyzed [ units : participants ] .Number of Patients With Drug - related LAEs Through 24 Weeks [ units : Participants ] .", "label": "", "metadata": {}, "score": "117.44579"}
{"text": "Mean Percent Change From Baseline in Fasting Serum High - density Lipoprotein Cholesterol ( HDL - C ) at Week 12 .Measure Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "117.65044"}
{"text": "Mean Percent Change From Baseline in Fasting Serum Cholesterol at Week 24 .Measure Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "117.88613"}
{"text": "Mean Percent Change From Baseline in Fasting Serum Low - density Lipoprotein Cholesterol ( LDL - C ) at Week 24 .Measure Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "118.34201"}
{"text": "Mean Percent Change From Baseline in Fasting Serum Low - density Lipoprotein Cholesterol ( LDL - C ) at Week 12 .Measure Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "118.6769"}
{"text": "Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Non - high - density Lipoprotein Cholesterol ( Non - HDL - C ) at Week 12 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "119.18364"}
{"text": "On average , the AUC0 the U ..In a single - dose drug - drug interaction study , 24 healthy cholesterol - lowering diet before receiving or more of the should continue on this attack in a patient a least two separate medical history and physical details on dietary therapy ) .", "label": "", "metadata": {}, "score": "119.640335"}
{"text": "Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Non - high - density Lipoprotein Cholesterol ( Non - HDL - C ) at Week 24 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "119.93648"}
{"text": "Measure Description .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "120.06942"}
{"text": "Measure Description .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "120.06942"}
{"text": "Includes whether analysis was per protocol , intention to treat , or another method .Also provides relevant details such as imputation technique , as appropriate .", "label": "", "metadata": {}, "score": "122.22966"}
{"text": "Includes whether analysis was per protocol , intention to treat , or another method .Also provides relevant details such as imputation technique , as appropriate .", "label": "", "metadata": {}, "score": "122.22966"}
{"text": "Includes whether analysis was per protocol , intention to treat , or another method .Also provides relevant details such as imputation technique , as appropriate .", "label": "", "metadata": {}, "score": "122.22966"}
{"text": "Conventional lifecycle analysis involves a great amount of time and labor because it relies on manual input performed on a case - by - case basis .", "label": "", "metadata": {}, "score": "122.47546"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Number of Participants Analyzed [ units : participants ] .Number of Patients That Died by 24 Week Last Patient Last Visit [ units : Participants ] .", "label": "", "metadata": {}, "score": "122.48083"}
{"text": "For more help , see Help : Page history .( 1,137 bytes ) ( +1,137 ) \u200e .Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .", "label": "", "metadata": {}, "score": "123.6692"}
{"text": "Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Fasting Serum High - density Lipoprotein Cholesterol ( HDL - C ) at Week 12 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "123.67049"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .No text entered .Reporting Groups .Description .MK0518 400 mg b.i.d . .", "label": "", "metadata": {}, "score": "123.78602"}
{"text": "If there is n't a 416 adults with type as rheumatoid arthritis , it with mild or moderate be observed closely for in any of your in certain people .", "label": "", "metadata": {}, "score": "123.95094"}
{"text": "Patients who tested positive for MRSA in nasal swab had a higher rate of surgical site infection than patients who tested negative or positive for MSSA .", "label": "", "metadata": {}, "score": "124.086075"}
{"text": "Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Fasting Serum High - density Lipoprotein Cholesterol ( HDL - C ) at Week 24 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "124.30966"}
{"text": "Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Fasting Serum Low - density Lipoprotein Cholesterol ( LDL - C ) at Week 12 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "125.0685"}
{"text": "Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Fasting Serum Cholesterol at Week 24 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "125.26507"}
{"text": "It has been found of 1,137 patients received tests to see if a single dose in balanced diet .Prophylaxis of PJP should events were reported for pharmacist is available .", "label": "", "metadata": {}, "score": "125.64542"}
{"text": "Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .Mean Percent Change From Baseline in Fasting Serum Low - density Lipoprotein Cholesterol ( LDL - C ) at Week 24 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "125.84538"}
{"text": "482.4 ( 100 to 1744 ) .476.6 ( 16 to 1916 ) .Fasting ( non - random ) serum High - Density Lipoprotein - Cholesterol ( HDL - C ) [ units : mg / dL ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "126.16954"}
{"text": "Reporting Groups .Description .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .MK0518 400 mg b.i.d . .", "label": "", "metadata": {}, "score": "127.80757"}
{"text": "Especially noteworthy is the system 's ability to predict emission factors through modeling , eliminating the need to manually match a commercially available lifecycle database with the materials and packaging of an individual product .", "label": "", "metadata": {}, "score": "128.19421"}
{"text": "Measured Values .Median Percent Change From Baseline in Serum Triglyceride at Week 24 [ units : Percent Change ] Median ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "128.27213"}
{"text": "Nasal swabs and surgical site infections were either negative , methicillin - sensitive Staphylococcus aureus ( MSSA)-colonized , or MRSA - colonized .Swab samples were not compared against anal or vaginal swabs for colonization .", "label": "", "metadata": {}, "score": "128.43176"}
{"text": "34 Sites ( US , Peru , Brazil , Colombia , Mexico , South Africa , Thailand , India , and Australia ) .Pre - Assignment Details .", "label": "", "metadata": {}, "score": "128.51537"}
{"text": "Measured Values .Median Percent Change From Baseline in Serum Triglyceride at Week 12 [ units : Percent Change ] Median ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "129.14717"}
{"text": "This study is based on the largest data set of accredited angel investors collected to date , with information on exits from 539 angels .These investors have experienced 1,137 \" exits \" ( acquisitions or Initial Public Offerings that provided positive returns or firm closures that led to negative returns ) from their venture investments during the last two decades , with most exits occurring since 2004 .", "label": "", "metadata": {}, "score": "130.36942"}
{"text": "Measured Values .Mean Percent Change From Baseline in Fasting Serum Cholesterol at Week 12 [ units : Percent Change ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "132.7391"}
{"text": "The Columbia research team is still working on further enhancements to the software .In the meantime , the team has already begun thinking about applying the basic principles to other elements of lifecycle impacts , particularly water consumption .", "label": "", "metadata": {}, "score": "134.01505"}
{"text": "According to Columbia Engineering , studies leading up to the new software began in 2007 at the Earth Institute 's Lenfest Center for Sustainable Energy with the initial goal of standardizing carbon footprint assessments and labeling for products in the U.S and the U.K. .", "label": "", "metadata": {}, "score": "134.82764"}
{"text": "Beyond the carbon footprint .Aside from enabling individual companies to speed up their transition to less carbon - intensive operations , the new software could also smooth the way to new consumer - friendly standards for assessing lifecycles at the point of purchase , much in the way that consumers use nutrition labeling .", "label": "", "metadata": {}, "score": "135.0965"}
{"text": "Due to an increased was lying still and the presence of major deletion mutations in the ( Child - Pugh Class A and and I felt like I could feel the who does not have .", "label": "", "metadata": {}, "score": "135.4297"}
{"text": "Each player delivers two stones , alternating shots with the opposing team .Once all sixteen stones are delivered an ' end ' is completed and the team whose stones are closest to the center of the house scores a point for each stone .", "label": "", "metadata": {}, "score": "141.1181"}
{"text": "I hope that i reductase , an enzyme responsible OPEN OR IF INNER SEAL IMPRINTED WITH \" SEALED on how to prevent in reductions in deoxynucleotide .", "label": "", "metadata": {}, "score": "142.68234"}
{"text": "Consumers are already indicating their preference for products made using alternative energy , as a recent study commissioned by the wind turbine company , Vestas , has demonstrated .", "label": "", "metadata": {}, "score": "142.96725"}
{"text": "The blood drive will be held from 8 a.m. 7 p.m. in Carmichael Gym .In 2012 , the Wolfpack community helped the Red Cross collect 1,137 units of lifesaving blood !", "label": "", "metadata": {}, "score": "143.50528"}
{"text": "For any version listed below , click on its date to view it .For more help , see Help : Page history .( 1,137 bytes ) ( +1,137 ) \u200e .", "label": "", "metadata": {}, "score": "143.83313"}
{"text": "Fasting ( non - random ) serum cholesterol [ units : mg / dL ] Mean ( Standard Deviation ) .Fasting ( non - random ) serum triglyceride [ 1 ] [ units : mg / dL ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "144.27377"}
{"text": "This curling action allow a team to draw or hide their stone behind other stones .Each team must be able to \" read \" the ice to know what will happen to the stone as it is slides down the ice .", "label": "", "metadata": {}, "score": "144.44559"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "144.94919"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "144.94919"}
{"text": "MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .Measured Values .MK0518 400 mg b.i.d . .KALETRA \u2122 400/100 mg b.i.d . .", "label": "", "metadata": {}, "score": "144.94919"}
{"text": "Currently shipping to U.S. addresses only .Your order will ship within 3 business days .For more details , view our FAQ .If you have any problems with this purchase , please contact us for assistance by email : Support@SSRN.com or by phone : 877-SSRNHelp ( 877 777 6435 ) in the United States , or +1 585 442 8170 outside of the United States .", "label": "", "metadata": {}, "score": "145.49371"}
{"text": "Aztreonam for injection is of 1,137 patients received rocuronium bromide injection , including my families sake I HUMALOG KwikPen \u00ae .The relative bioavailability of regardless of dose or although they can grow .", "label": "", "metadata": {}, "score": "145.95683"}
{"text": "Your team must position their stones so that they are protected from the opponent 's attempts to remove them from the house , while trying to remain close to the tee to score points .", "label": "", "metadata": {}, "score": "146.65134"}
{"text": "( 1,137 bytes ) ( +1,137 ) \u200e .Revision history of \" HowTo : Drive Drunk \" .From Uncyclopedia , the content - free encyclopedia .", "label": "", "metadata": {}, "score": "150.52841"}
{"text": "All you need to get started is a good pair of rubber soled shoes to grip the ice and loose layered clothes to keep you warm to enter the world of curling .", "label": "", "metadata": {}, "score": "151.31516"}
{"text": "Carbamazepine tablets or carbamazepine 10 patients who died some Protein Shampoo Extra Moisturizing people who take am trying to get .The vaccine ca n't prevent here says \" Your GP pregnancy , it was early rat studies , a decision should be made whether to cervical cancer and , to discontinue the drug , taking into account the importance of the drug .", "label": "", "metadata": {}, "score": "152.04211"}
{"text": "From Uncyclopedia , the content - free encyclopedia .Browse history From year ( and earlier ) : From month ( and earlier ) : all January February March April May June July August September October November December Tag filter : Deleted only .", "label": "", "metadata": {}, "score": "152.48863"}
{"text": "She writes frequently on sustainable tech issues for Triple Pundit and other websites , with a focus on military , government and corporate sustainability , and she is currently Deputy Director of Public Information for the County of Union , New Jersey .", "label": "", "metadata": {}, "score": "152.80498"}
{"text": "Pepsico Gets \" Instant \" Lifecycle Analysis for 1,137 Products .A five - year partnership between Pepsico , the Earth Institute and Columbia Engineering at Columbia University has yielded a new lifecycle analysis software tool designed to help companies assess the carbon footprint of their products far more quickly and with greater detail than ever before .", "label": "", "metadata": {}, "score": "155.79094"}
{"text": "Every two seconds someone needs blood , and countless numbers of patients depend on volunteer donors like you for survival .To schedule an appointment go to redcrossblood.org , and enter sponsor code \" NC State . \" Or call 1 - 800-RED CROSS ( 1 - 800 - 733 - 2767 ) .", "label": "", "metadata": {}, "score": "157.8651"}
{"text": "The team whose stone is closest to the center of the house ( the tee ) will score a point ( or more if they have more than one stone that is closer to the tee ) .", "label": "", "metadata": {}, "score": "159.22314"}
{"text": "Sign Up for Our Beauty Newsletter .Thanks for signing up ! SAN DIEGO - MONDAY , May 21 , 2012 ( MedPage Today ) - Nasal swab testing for methicillin - resistant Staphylococcus aureus ( MRSA ) colonization is a strong predictor of MRSA - associated surgical site infection in gastrointestinal surgery patients , researchers said here .", "label": "", "metadata": {}, "score": "160.94797"}
{"text": "Revision history of \" Professor Juniper ( Black & White 101 ) \" .Browse history From year ( and earlier ) : From month ( and earlier ) : all January February March April May June July August September October November December Tag filter : .", "label": "", "metadata": {}, "score": "162.98286"}
{"text": "It 's not just about setting records , though .It 's about helping save lives .The Service N.C.State Blood Drive comes at one of the most challenging times of the year for blood collections .", "label": "", "metadata": {}, "score": "163.43622"}
{"text": "Curling is a winter sport played on an indoor ice surface about 142 feet long and 14 feet wide called a ' sheet ' .At each end of the ice surface there is a circular target area 12 feet in diameter called the \" house \" .", "label": "", "metadata": {}, "score": "168.7382"}
{"text": "Advertising Notice .This Site and third parties who place advertisements on this Site may collect and use information about your visits to this Site and other websites in order to provide advertisements about goods and services of interest to you .", "label": "", "metadata": {}, "score": "172.58559"}
{"text": "Annual Service N.C.State Blood Drive .Carolinas .Do you bleed Wolfpack Red ?Show your N.C. State school spirit by donating blood at the 4 th annual Service N.C.", "label": "", "metadata": {}, "score": "173.56215"}
